// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

SITAGLIPTIN IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Tisha R. Joy - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

Sitagliptin

ALBUMIN USE AND ACUTE KIDNEY INJURY IN A LARGE REAL-WORLD ANALYSIS OF CIRRHOTIC INPATIENTS

Jacqueline G. O'Leary - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

IRRITABLE BOWEL SYNDROME PATIENT EXPERIENCE IN CANADA

Guy Aumais - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

INVOLVEMENT OF INOS-DERIVED NO IN THE IMPAIRMENT OF MOUSE VAGAL AFFERENT SENSITIVITY IN DIET INDUCED OBESITY

Sung Jin Park - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Nitroprusside sodium

THE INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP1B) RECOVERS IMPAIRED VAGAL AFFERENT INDUCED DURING DIET-INDUCED OBESITY THROUGH REDUCTION IN NITRIC OXIDE AND TWO-PORE DOMAIN K+ CONDUCTANCE

Michael Beyak - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Nitric oxide

VAGAL AFFERENT DYSFUNCTION INVOLVES SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS3) MEDIATED NITRIC OXIDE PRODUCTION IN DIET-INDUCED OBESITY AND ELEVATED LEPTIN CONDITIONS

Michael Beyak - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Zoledronic acid

GLUTEN FREE DIET IMPROVES UPPER GI SYMPTOMS AND PROMOTES CHANGES IN GASTRIC EMPTYING IN IBS PATIENTS WITH FUNCTIONAL DYSPEPSIA

Natalia Causada Calo - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

COLDER WEATHER AND FEWER SUNLIGHT HOURS INCREASE THE WEIGHT OF ALCOHOL AS A CAUSE OF CIRRHOSIS WORLDWIDE

Monica Cruz-Lemini - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

OUTCOME OF FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION ON QUALITY OF LIFE

Peter T. Kim - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

DIARRHEA AND CLOSTRIDUM DIFFICILE INFECTION IN THE ICU: A MULTICENTER STUDY

Erick H. Duan - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

EFFECT OF TIME TO OPERATION ON OUTCOMES IN ADULTS WHO UNDERWENT AN EMERGENCY GENERAL SURGERY PROCEDURE: A LOCAL ACS-NSQIP RETROSPECTIVE ANALYSIS

Arash Azin - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

LACK OF ASSOCIATION WITH PATIENT DEMOGRAPHICS AND OUTCOMES IN PUNCH CD 2, A RANDOMIZED CONTROLLED TRIAL OF RBX2660, A MICROBIOTA-BASED DRUG FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION

Robert Orenstein - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

RBX2660

CLINICAL SYMPTOMS CORRELATE POORLY WITH ENDOSCOPIC INFLAMMATION IN PEDIATRIC PSC-IBD

Nicholas Carman - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

CHOICE OF EXCLUSIVE ENTERAL NUTRITION (EEN) INDUCTION THERAPY IN PEDIATRIC Crohn's DISEASE IS ASSOCIATED WITH INCREASED USE OF SMALL BOWEL IMAGING AND DETECTION OF ILEAL DISEASE EXTENSION

Sana Basseri - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

FIBRE INTAKE IS ASSOCIATED WITH MICROBIOME CHANGES IN PEDIATRIC Crohn's DISEASE PATIENTS FOLLOWING INDUCTION OF REMISSION WITH EXCLUSIVE ENTERAL NUTRITION (EEN)

Jessica Connors - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

ROLE OF GUT SEROTONIN IN THE PRODUCTION OF ANTIMICROBIAL PEPTIDES

Huaqing Wang - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

tryptophan

REDUCED NEUTROPHIL GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR SIGNALING IS ASSOCIATED WITH GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR ALPHA CHAIN GENE MUTATIONS AND STRICTURING DISEASE COMPLICATIONS IN PEDIATRIC CROHN DISEASE

Ingrid Jurickova - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

GM-CSF

LOW NEUTROPHIL REACTIVE OXYGEN SPECIES PRODUCTION IS ASSOCIATED WITH NICOTINAMIDE-ADENINE DINUCLEOTIDE PHOSPHATE (NADPH) OXIDASE GENE MUTATIONS AND REFRACTORY COLONIC INVOLVEMENT IN PEDIATRIC CROHN DISEASE

Ingrid Jurickova - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Nicotinamide

HERPES ZOSTER INFECTION AND HERPES ZOSTER VACCINATION IN IBD: A NEED FOR IMPROVEMENT IN VACCINATION RATES

Harminder Singh - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

THE WORLDWIDE INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN THE 21ST CENTURY: A SYSTEMATIC REVIEW OF POPULATION-BASED STUDIES

Hai Yun Shi - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved